Avatar Medical, a French company founded in 2020, has achieved a significant regulatory milestone with CE Marking for its Avatar Medical Vision software, the first such clearance for a platform designed to work with glasses-free 3D medical displays. The announcement, made at the Journées Francophones de Radiologie (JFR 2026) in Paris, paves the way for commercialization across Europe and positions the company to accelerate adoption in two of the world's largest healthcare markets.
The CE Marking allows surgeons and patients to benefit from the same depth perception typically associated with virtual reality headsets, but without the need for any wearable device. According to the company, the absence of headsets eliminates common clinical drawbacks such as cleaning requirements, cable management, and occasional hardware unreliability. This makes glasses-free 3D far better suited to everyday clinical settings, from initial patient consultations to detailed surgical planning. For hospitals and clinics, this could mean smoother workflows, reduced equipment maintenance, and more intuitive communication between medical teams and patients.
This latest certification builds on Avatar Medical Vision's initial CE Marking in 2025, expanding its capabilities to include glasses-free 3D visualization. With regulatory clearances now in both Europe and the United States, Avatar Medical is well-positioned to pursue broader adoption across two major healthcare markets. The company's technology converts CT and MRI scans into interactive, lifelike 3D visualizations instantly and without segmentation, giving clinicians a more intuitive way to understand patient-specific anatomy. This advancement strengthens two critical steps of the surgical care journey: consultation and surgical planning, by making complex anatomy easier to grasp across multiple medical specialties.
The broader implications for the medical imaging industry are notable. Avatar Medical is pioneering what it calls Visual Intelligence for Surgery, a scalable solution that transforms medical imaging into actionable visual information throughout the surgical care journey. By focusing on making visual intelligence accessible wherever critical surgical decisions are made, the company aims to improve collaboration and patient communication. For healthcare providers, this could lead to better surgical outcomes and more efficient use of imaging data. For patients, it may result in clearer explanations of their conditions and greater confidence in proposed procedures.
Avatar Medical already works with more than 20 hospitals across the U.S. and Europe, and its FDA-cleared and CE-marked products underscore its growing regulatory footprint. The company's origins from research conducted at Institut Curie and Institut Pasteur add further scientific credibility. For more details on the full announcement, including downloadable images and bios, click here. Additional information is available at avatarmedical.ai, and media resources can be found in the press kit.
As healthcare systems continue to seek technologies that enhance precision and efficiency, Avatar Medical's glasses-free 3D solution represents a step forward in making advanced visualization a practical, everyday tool for clinicians. The CE Marking not only validates the technology's safety and performance but also signals a new phase of growth for the company, with potential ripple effects across surgical planning, medical training, and patient engagement. The coming months will reveal how quickly European hospitals integrate this innovation into routine practice, and whether it sets a new standard for medical displays.
